Transgender Women’s Interventions: Pilot and Evaluation
ID: 352288Type: Forecasted
Overview

Buyer

Centers for Disease Control - NCHHSTP (HHS-CDC-NCHHSTP)

Award Range

$8M - $8M

Eligible Applicants

Unrestricted

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/352288
Timeline
  1. 1
    Forecast Posted Jun 30, 2024 12:00 AM
  2. 2
    Forecast Due Not available
  3. 3
    Posted Feb 9, 2024 12:00 AM
  4. 4
    Due Not available
Description

The Centers for Disease Control - NCHHSTP is forecasting a federal grant opportunity titled "Transgender Women's Interventions: Pilot and Evaluation". This opportunity falls under the category of Health and is a Cooperative Agreement. The grant is for a non-research pilot and program evaluation of two HIV prevention interventions for transgender women. The estimated total program funding is $8,400,000, with an expected number of 8 awards. The grant requires no cost sharing or matching requirement. The eligible applicants are unrestricted, but the NOFO is specifically seeking applications from organizations that currently serve transgender women and are rooted or embedded within this community. Applicants may provide HIV prevention services in a maximum of three service areas within their jurisdiction, including areas that cross over into bordering state health department jurisdictions. Applicants must have a history of providing HIV prevention services in their jurisdiction, have discussed provision of services with their state or local health department, and have received written consent from their state or local health department. Additional required documents include a Health Department Agreement for HIV Testing Letter, Service Agreement(s) with HIV Medical Care Provider(s), Service Agreement(s) with PrEP provider(s), and documents that demonstrate engagement and provision of HIV prevention services to transgender women. The grant has an award ceiling and floor of $8,400,000. The estimated synopsis post date is June 30, 2024, and the estimated synopsis close date is October 9, 2024. Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. The estimated award date is April 21, 2025, and the estimated project start date is May 12, 2025. For more information, you can contact Andrea Moore at AMoore@cdc.gov or 404 639 6262.

Point(s) of Contact
Andrea Moore
(404) 639-6262
AMoore@cdc.gov
Files
No associated files provided.
Similar Opportunities
Implementation and Evaluation of PrEPmate: An evidence-based short message service/text-based PrEP intervention for YMSM and Transgender women of color
Active
Centers for Disease Control - NCHHSTP
The Centers for Disease Control - NCHHSTP is forecasting a federal grant opportunity titled "Implementation and Evaluation of PrEPmate: An evidence-based short message service/text-based PrEP intervention for YMSM and Transgender women of color". This grant aims to implement and evaluate PrEPmate, a mobile health (mHealth) intervention designed to increase HIV pre-exposure prophylaxis (PrEP) adherence and retention in PrEP care among young men who have sex with men (YMSM) and transgender women of color. PrEPmate features youth-tailored interactive content, reminders, short message service (SMS) for PrEP clinic patients and clinical providers, and a dashboard for patient monitoring. The recipient of the grant will facilitate the implementation of PrEPmate at three clinical sites in the southern region of the United States, where there is a higher burden of HIV disease. The project will monitor and evaluate how the mHealth intervention is integrated into clinical services to improve PrEP adherence and retention in care. The evaluation will involve EMR reviews and interviews with agency staff. The primary outcomes of the project include increased PrEP medication adherence and retention in PrEP care among patients, as well as increased adaptability and sustainability among clinical providers. The secondary outcome will be the identification of best practices and lessons learned for implementing PrEPmate in clinics serving YMSM and transgender women of color. The estimated total program funding for this opportunity is $3,000,000, and it is expected to result in one award. The application due date is March 7, 2025, and the estimated award date is July 1, 2025. For more information, you can contact Charles Collins, Senior Health Scientist, at 404-639-0966 or cwc4@cdc.gov.
Demonstration Projects for Comprehensive and Integrated HIV Care, Treatment, Prevention and Essential Support Service Models for Cis-gender Black Women (CgBW) in the South
Active
Centers for Disease Control - NCHHSTP
The Centers for Disease Control - NCHHSTP is forecasting a grant opportunity titled "Demonstration Projects for Comprehensive and Integrated HIV Care, Treatment, Prevention and Essential Support Service Models for Cis-gender Black Women (CgBW) in the South." This grant aims to address racial/ethnic disparities in HIV infection among Cis-gender Black women (CgBW) in the United States. CgBW account for the largest percentage of women living with HIV and the highest number of annual HIV infections among women. The grant seeks to fund organizations that can offer integrated care service models to provide HIV care and treatment, as well as other health care and essential support services, to Cis-gender Black women with HIV (CgBWH) through Community and Clinic Collaboratives (CCCs). These CCCs will consist of clinics, federally qualified health centers (FQHCs), community-based organizations (CBOs), and local and state health departments (HDs) serving CgBW. The funded organizations will be responsible for screening, navigating, and linking CgBWH to comprehensive and integrated health services, including chronic disease care, reproductive health, primary care, pediatric care, and aging-related services. The grant recipients will be expected to implement four strategies: (1) offering comprehensive and integrated models of care through CCCs, (2) providing whole person health screening, navigation, and linkage to STI and behavioral health services, (3) delivering culturally and linguistically responsive services that address stigma and medical mistrust, and (4) participating in a national learning collaborative to share best practices and lessons learned. The key outcomes of this project include increasing the number of CgBWH who initiate rapid ART, achieve viral suppression, and have their needs met for mental health and substance use disorder services, as well as other essential support services. The estimated total program funding for this grant is $7,500,000, and it is expected to result in three awards. The application due date is March 28, 2025, and the estimated award date is July 28, 2025. For more information, you can contact Jerris Raiford, the Project Officer, at (770) 488-0691 or HRBNOFO@cdc.gov.
High-Impact HIV Prevention and Surveillance Programs for Health Departments: Accelerating Pre-Exposure Prophylaxis (PrEP) Uptake for Ending the HIV Epidemic in the United States
Active
Centers for Disease Control - NCHHSTP
The Centers for Disease Control - NCHHSTP has announced a forecasted opportunity titled "High-Impact HIV Prevention and Surveillance Programs for Health Departments: Accelerating Pre-Exposure Prophylaxis (PrEP) Uptake for Ending the HIV Epidemic in the United States". This opportunity falls under the category of Health and is a Cooperative Agreement. The estimated total program funding is $1,750,000, with an expected number of 4 awards. The opportunity is focused on accelerating progress towards achieving the national HIV prevention goal of 50% pre-exposure prophylaxis (PrEP) coverage by the end of 2025. It aims to increase access to and uptake of PrEP for priority populations, such as Black and Latino gay, bisexual, and other men who have sex with men (MSM), and Black cisgender and transgender women. The period of performance for the supplemental funding is September 30, 2024, to May 31, 2025, with the possibility of continuing implementation during PS24-0047 Budget Year 2. Interested applicants must submit their applications by August 31, 2024, and the estimated award date is September 30, 2024. For more information, contact Erica K. Dunbar at 404-639-5230 or email NOFOINFO@cdc.gov.
Improving prevention, treatment, and care services for HIV and TB for target populations in the Dominican Republic under the President's Emergency Plan for AIDS Relief (PEPFAR)
Active
Centers for Disease Control-GHC
The Centers for Disease Control-GHC is forecasting a federal grant opportunity titled "Improving prevention, treatment, and care services for HIV and TB for target populations in the Dominican Republic under the President's Emergency Plan for AIDS Relief (PEPFAR)". This cooperative agreement falls under the category of Health and has a funding instrument type of Cooperative Agreement. The grant does not require cost sharing or matching. The estimated total program funding is $0, with an expected number of awards being 2. The goal of this grant is to provide high-quality, friendly HIV clinical services to people living with HIV in the Dominican Republic, with a focus on persons of Haitian descent. The services include improving access to HIV testing, providing HIV treatment and TB preventive therapy (TPT), and ensuring people living with HIV are retained on lifelong quality treatment to achieve viral suppression. The grant also aims to advocate for services that align with international standards, such as same-day antiretroviral therapy (ART) and multi-month dispensing. Additionally, the grant seeks to serve the needs of persons of Haitian descent by using community-based approaches. The grant opportunity is forecasted to have an award ceiling of $0 for Year 1, with an approximate total fiscal year funding amount of $5,600,000 for Year 1, subject to the availability of funds. The estimated project start date is September 30, 2025, and the estimated award date is also September 30, 2025. The grant application must be electronically submitted by 11:59 pm ET on the listed application due date, which is February 17, 2025. For more information or to apply for this grant opportunity, please contact Emily Dale at (404) 639-8880 or email pepfarfoas@cdc.gov.
Transgender People: Immunity, Prevention, and Treatment of HIV and STIs (R21 Clinical Trial Not Allowed)
Active
National Institutes of Health
The National Institutes of Health is offering a grant opportunity titled "Transgender People: Immunity, Prevention, and Treatment of HIV and STIs (R21 Clinical Trial Not Allowed)". This grant aims to support hypothesis-generating research in transgender individuals to characterize the biological and immunological impact of interventions used for gender reassignment and their effect on susceptibility to HIV and other sexually transmitted infections (STIs). The grant does not require cost sharing or matching requirements and falls under the category of Health. The maximum award ceiling for this grant is $275,000. The eligible applicants include various institutions and organizations such as Alaska Native and Native Hawaiian Serving Institutions, Faith-based or Community-based Organizations, and U.S. Territories or Possessions. The closing date for this grant opportunity is December 7, 2024. For more information and to apply, please visit the following link: [http://grants.nih.gov/grants/guide/pa-files/PAR-22-186.html](http://grants.nih.gov/grants/guide/pa-files/PAR-22-186.html). For any inquiries, please contact NIH OER Webmaster at OERWebmaster03@od.nih.gov.